plasma osteocalcin (Millipore)
Millipore is a verified supplier 
90
Structured Review
Millipore
plasma osteocalcin
Plasma Osteocalcin, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasma+osteocalcin/plasma+osteocalcin/pm21887702-114-50-52
Average 90 stars, based on 1 article reviews
Plasma Osteocalcin, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasma+osteocalcin/plasma+osteocalcin/pm21887702-114-50-52
Average 90 stars, based on 1 article reviews
plasma osteocalcin - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Clinical Proteomics:Article Title: Gender-specific increase of bone mass by CART peptide treatment is ovary-dependent. Article Snippet: Cocaineand amphetamine-regulated transcript (CART) has emerged as a neurotransmitter and hormone that has been implicated in many processes including food intake, maintenance of body weight, and reward, but also in the regulation of bone mass.. CART-deficient mice are characterized by an osteoporotic phenotype, whereas female transgenic mice overexpressing CART display an increase in bone mass.. Here we describe experiments that show that peripheral subcutaneous sustained release of different CART peptide isoforms for a period up to 60 days increased bone mass by 80% in intact mice. Plex Assay:Article Title: Gender-specific increase of bone mass by CART peptide treatment is ovary-dependent. Article Snippet: Cocaineand amphetamine-regulated transcript (CART) has emerged as a neurotransmitter and hormone that has been implicated in many processes including food intake, maintenance of body weight, and reward, but also in the regulation of bone mass.. CART-deficient mice are characterized by an osteoporotic phenotype, whereas female transgenic mice overexpressing CART display an increase in bone mass.. Here we describe experiments that show that peripheral subcutaneous sustained release of different CART peptide isoforms for a period up to 60 days increased bone mass by 80% in intact mice. Enzyme-linked Immunosorbent Assay:Article Title: Gender-specific increase of bone mass by CART peptide treatment is ovary-dependent. Article Snippet: Cocaineand amphetamine-regulated transcript (CART) has emerged as a neurotransmitter and hormone that has been implicated in many processes including food intake, maintenance of body weight, and reward, but also in the regulation of bone mass.. CART-deficient mice are characterized by an osteoporotic phenotype, whereas female transgenic mice overexpressing CART display an increase in bone mass.. Here we describe experiments that show that peripheral subcutaneous sustained release of different CART peptide isoforms for a period up to 60 days increased bone mass by 80% in intact mice. |